Medical device, drug-like
OtherEctoin Allergy Nasal Spray
NCT Number: NCT02133053
This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray. The patient applies Ectoin® Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ectoin Allergy Nasal Spray
Beclomethasone nasal spray
Time frame: Time Frame: day 1, day 7, day 14
Time frame: Day 1, 7 and 14
Time frame: day 7 and 14
Time frame: Day1 and Day 14
Bitop AG
Industry
Non Interventional Study of Ectoin Allergy Nasal Spray Compared to Beclomethasone Nasal Spray
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03075917
Allergic Rhinitis, Hypersensitivity
Bagnols-sur-Cèze, France
View Trial DetailsNCT05346718
Allergic Rhinitis, Birch Pollen Allergy
Hanover, Lower Saxony, Germany
View Trial DetailsNCT06916884
Allergic Rhinitis, Hypersensitivity
Mexico City, Mexico
View Trial DetailsNCT05476484
Allergic Rhinitis, Allergy
Hørsholm, Copenhagen, Denmark
View Trial Details